XRCC1 and cancer: The cancer cells over‐expressed XRCC1 resist to camptothecin and the XRCC1 deficient cells are sensitive to camptothecin.35, 36 Therefore, these data suggest XRCC1 would be an important target for BBR to function in DNA repair.